A cardiovascular specialty hospital in north Texas decreased time to diagnosis for patients with cardiogenic shock by more than half, according to a study published in Critical Care Nurse.

Windtree Therapeutics, Inc. (NasdaqCM: WINT) recently showcased promising data on istaroxime, an investigational treatment ...

Cardiogenic dementia is a condition where heart disease can increase a person’s risk of cognitive problems. People with heart disease, chronic diseases of the cardiovascular system, and smokers ...

Upon arrival, she was cyanotic, restless, in cardiogenic shock, and had cold extremities with undetectable blood pressure.

Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases, today announced that ...

Windtree Therapeutics (WINT) announced that Alexandre Mebazaa, MD, one of the world’s recognized leaders in cardiogenic shock, gave a ...